GENETIC POLYMORPHISM OF CYP3A5 AS A KEY REGULATOR OF PHARMACOKINETICS OF TACROLIMUS IN KIDNEY TRANSPLANT PATIENTS: EVIDENCE IN KAZAKH POPULATION

View PDF file